College: Harvard University, 1989, A.B. (Magna Cum Laude, Biology)
Medical School: University of Chicago Pritzker School of Medicine, 1994, M.D.
Internship: University of Chicago, Internal Medicine, 1994-1995, 1996-1998
Residency: University of California San Francisco, Anesthesiology, 1995-1996
Fellowship: University of California San Diego, Pulmonary and Critical Care Medicine, 1998-2001
Faculty at UCSD since 2001. Fellowship program director 2009-2017. Currently, Professor of Medicine in the Division of Pulmonary, Critical Care, Sleep Medicine, & Physiology. Section Chief of Pulmonary Vascular Medicine. Medical Director of Pulmonary Thromboendarterectomy Program.
Evaluation and treatment of pulmonary arterial hypertension
Interventional and medical management of chronic thromboembolic disease
Perioperative management following pulmonary thromboendarterectomy
Balloon pulmonary angioplasty for chronic thromboembolic disease
Clinical trials in pulmonary hypertension
As of Nov 2025: 132 peer-reviewed publications on pulmonary hypertension including, pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Lead author for the 5th, 6th, and 7th World Symposium on Pulmonary Hypertension task force on “Chronic Thromboembolic Pulmonary Hypertension”. 4th World Symposium on Pulmonary Hypertension task force member: “Endpoints and Clinical Trial Design in PAH” and “Interventional and Surgical Modalities of Treatment in PH”.
1976 – 1978 Premedical Course, Tokyo Medical and Dental University, Chiba, Japan
1978 – 1982 M.D., Tokyo Medical and Dental University, Tokyo, Japan
2000 Ph.D. (Doctor of Medicine), Tokyo Medical and Dental University, Tokyo, Japan
1991 Board certified in Pediatrics, Japanese Pediatric Society
2011 Board certified in Pediatric Cardiologist, Japanese Society of Pediatric Cardiology and Cardiac Surgery
2011 Board certified in PALS provider, American Heart Association
Japanese Medical Specialty Board and Instructor of Pediatrics
Specialty Board of Pediatric Cardiology
Honorary fellow of Japanese Society of Pediatric Cardiology and Cardiac Surgery
Honorary fellow of Japanese Pulmonary Circulation and Pulmonary Hypertension Society
Implantable Cardioverter Defibrillator for Primary Prevention in Children With Arrhythmogenic Right Ventricular Cardiomyopathy: A Case Series. Cureus. 2025 Jan 10;17(1):e77253
Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries. J Clin Med. 2026 Jan 30;15(3):1087. doi: 10.3390/jcm15031087